Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Aurobindo pharma has got USFDA approval to manufacture multi disease treatment injection

On Wednesday, Aurobindo Pharma said that it has received final approval from the US Food and Drug Administration (USFDA) for manufacturing and marketing Dexamethasone Sodium Phosphate Injection USP, 4mg/mL (1 mL, 5mL, and 30 mL vials) in USA .

The company has said in a statement that the product is expected to be launched by the last quarter of the current fiscal.

It further said that “the approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Dexamethasone Sodium Phosphate Injection USP, 4 mg/mL, of Luitpold Pharmaceuticals Inc”.

Read EquityPandit’s Nifty Pharma Outlook for this week

Get Daily Prediction & Stocks Tips On Your Mobile